Less than a decade ago, aspirin seemed to be losing some of its luster. Marketed since the beginning of the century as a uniquely effective pain and fever fighter, it was suddenly forced to compete with two major rivals -- acetaminophen (Tylenol, Anacin-3) and ibuprofen (Advil, Nuprin) -- that had many of aspirin's benefits without some of its side effects. Worse, aspirin had been linked to Reye's syndrome, a rare but sometimes deadly condition that can afflict children after a bout of flu or chickenpox. Doctors immediately ceased to recommend it for most youngsters, and liquid Tylenol replaced orange-flavored children's aspirin...
To continue reading:
or
Log-In
